Medicines for Malaria Venture, estimated health benefits per $1 invested, 2000–23. Base case
Note: scenarios vary the discount rate, the disability-adjusted life-years (DALYs) averted and how health gains are valued in money (income elasticity). The authors include MMV and UK government staff.
Source: Christen et al., The Lancet Global Health (2026)
| Scenario | Benefits per $1 invested |
|---|---|
| Higher DALY estimate | $16.32 |
| Higher discount rate (5%) | $14.07 |
| Base case | $12.99 |
| Lower discount rate (2%) | $12.31 |
| Lower DALY estimate | $8.98 |
| Higher income elasticity | $3.84 |